Mycoplasma hyopneumoniae bacterins and porcine circovirus type 2 (PCV2) infection: Induction of postweaning multisystemic wasting syndrome (PMWS) in the gnotobiotic swine model of PCV2-associated disease

Canadian Veterinary Journal

Volumn 48, Issue 7, 2007, Pages 716-724

  Krakowka, Steven ^a   Ellis, John ^b   McNeilly, Francis ^c   Waldner, Cheryl ^b   Rings, D Michael ^a   Allan, Gordon ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; HEMOCYANIN; IMMUNOLOGICAL ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; KEYHOLE-LIMPET HEMOCYANIN; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL DISEASE; ARTICLE; CIRCOVIRIDAE; DISEASE MODEL; GERMFREE ANIMAL; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MYCOPLASMA HYOPNEUMONIAE; PATHOGENICITY; PATHOLOGY; PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME; RANDOMIZATION; SWINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL VACCINES; CIRCOVIRUS; DISEASE MODELS, ANIMAL; GERM-FREE LIFE; HEMOCYANIN; IMMUNOHISTOCHEMISTRY; MYCOPLASMA HYOPNEUMONIAE; PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME; RANDOM ALLOCATION; SEVERITY OF ILLNESS INDEX; SWINE;

CIRCOVIRIDAE; MYCOPLASMA HYOPNEUMONIAE; PORCINE CIRCOVIRUS 2; SUIDAE;

EID: 34547756501     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Clark EG. Post-weaning multisystemic wasting syndrome. Proc Am Assoc Swine Pract 1997:499-501.
2. Harding J. Post-weaning multisystemic wasting syndrome (PMWS): Preliminary epidemiology and clinical presentation. Proc Am Assoc Swine Pract 1997:503.
3. Allan GM, Ellis JA. Porcine circoviruses: A review. J Vet Diagn Invest 2000;12:3-14.
4. Segales J, Domingo M. Postweaning multisystemic wasting syndrome (PMWS) in pigs. A review. Vet Q 2002;24:109-124.
5. West KW, Bystrom JM, Wojnarowicz C, et al. Myocarditis and abortion associated with intrauterine infection of sows with porcine circovirus. J Vet Diag Invest 1999;11:530-532.
6. Bogdan J, West K, Clark E, et al. Association of porcine circovirus 2 with reproductive failure in pigs: A retrospective study. 1995-1999. Can Vet J 2001;42:548-550.
7. Harms PA, Halbur PG, Sorden SD. Three cases of porcine respiratory disease complex associated with porcine circovirus type 2 infection. J Swine Health Prod 2002;10:33-38.
8. Kim J, Chung HK, Chae C. Association of porcine circovirus 2 with porcine respiratory disease complex. Vet J 2003;166:251-256.
9. Ellis JA, Krakowka S, Lairmore M, et al. Reproduction of lesions of post-weaning multisystemic wasting syndrome in gnotobiotic piglets. J Vet Diag Invest 1999;11:3-14.
10. Krakowka S, Ellis JA, Meehan B, Kennedy S, McNeilly F, Allan G. Viral wasting syndrome of swine: Experimental reproduction of postweaning multisystemic wasting syndrome by co-infection with porcine circovirus-2 (PCV 2) and porcine parvovirus (PPV). Vet Pathol 2001;37:254-263.
11. Allan GM, Kennedy S, McNeilly F, et al. Experimental reproduction of wasting disease and death by co-infection of piglets with porcine circovirus and porcine parvovirus. J Comp Pathol 1999;121:1-11.
12. Allan GM, McNeilly F, Ellis JA, et al. Experimental infection of colostrum deprived piglets with porcine circovirus type 2 (PCV-2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV-2 replication. Arch Virol 2000;145:2421-2429.
13. Ellis J, Clark E, Haines D, et al. Porcine circovirus-2 and concurrent infections in the field. Vet Microbiol 2004;98:159-163.
14. Fenaux M, Halbur PG, Haqshenas G, et al. Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: Characterization of clinical disease, virus distribution, and pathologic lesions. J Virol 2002;76:541-551.
15. Krakowka S, Ellis JA, Meehan B, Ringler S, Rings MD, Allan G. In vivo Immune activation is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2). Vet Pathol 2001;38:31-42.
16. McNeilly F, Kennedy S, Moffett D, et al. A comparison of in situ hybridization and immunohistochemistry for the detection of a new porcine circovirus in formalin-fixed tissues from pigs with postweaning multisystemic wasting syndrome (PMWS). J Virol Methods 1999;80:123-128.
17. Rosell C, Segales J, Plana-Duran J, et al. Pathological, immunohistochemical and in situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs. J Comp Pathol 1999;120:59-78.
18. Sarli G, Mandrioli L, Laurenti M, et al. Immunohistochemical characterization of the lymph node reaction in pig postweaning multisystemic wasting syndrome. Vet Immunol Immunopathol 2001;83:53-67.
19. Krakowka S, Ellis J, McNeilly F, Meehan B, Waldner C, Allan G. Features of porcine circovirus (PCV)-2 disease: Correlations between lesions, amount and distribution of virus and clinical outcome. J Vet Diag Invest 2005;17:213-222.
20. Kyriakis SC, Saoulidis K, Lekkas S, Miliotis CC, Papoutis PA, Kennedy S. The effects of immuno-modulation on the clinical and pathological expression of postweaning multisystemic wasting syndrome. J Comp Pathol 2002;126:38-46.
21. Allan GM, McNeilly F, Kennedy S, Meehan B, Ellis J, Krakowka S. Immunostimulation, PCV-2 and PMWS. Vet Rec 2000;147: 170-171.
22. Allan GM, McNeilly F, Ellis JA, Krakowka S. Neonatal vaccination for Mycoplasma hyopneumoniae and postweaning multisystemic wasting syndrome: A field trial. Pig J 2001;48:34-41.
23. Opressnig T, Yu S, Gallup JM, et al. Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet Pathol 2003;40:521-529.
24. Resendes A, Segales J, Balasch M, et al. Lack of an effect of a commercial vaccine adjuvant on the development of postweaning multisystemic wasting syndrome (PMWS) in porcine circovirus type 2 (PCV2) experimentally infected pigs. Vet Res 2004;35:83-90.
25. Krakowka S, Eaton KA. Helicobacter pylori infection in gnotobiotic piglets: A model of human gastric bacterial disease. In: Tumbleson M, Shook L, eds. Advances in Swine in Biomedical Research, Vol 2, 1st ed. New York: Plenum Pr, 1996:779-810.
26. Dulac GC, Afshar A. Porcine circovirus antigens in PK-15 cell line (ATCC-CCL-33) and evidence of antibodies to circovirus in Canadian piglets. Can J Vet Res 1989;53:431-433.
27. McNeilly F, McNair I, Mackie DP, et al. Production characterization and applications of monoclonal antibodies to porcine circovirus type 2. Arch Virol 2001;146:909-922.
28. Krakowka S, Ellis JA, McNeilly F, et al. Immunologic features of porcine circovirus type 2 infection. Viral Immunol 2002;15:567-582.
29. Brunborg IM, Moldal T, Jonassen CM. Quantification of porcine circovirus type 2 from serum/plasma and tissue samples of healthy pigs and pigs with postweaning multisystemic wasting syndrome using TaqMan-based real-time PCR. J Virol Methods 2004;122:171-178.
30. Cheung A, Bolin SR. Kinetics of type 2 porcine circovirus replication. Arch Virol 2002;147:43-58.
31. Nawagitgul P, Morozov I, Bolin SR, Harms PA, Sorden SD, Paul PS. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J Gen Virol 2000;81:2281-2287.
32. Gilpin DF, McCullough KC, Meehan BM, et al. In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system. Vet Immunol Immunopathol 2003;94:149-161.
33. Harms PA, Sorden S, Halbur PG, et al. Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine respiratory and reproductive syndrome virus. Vet Pathol 2001;38:528-539.
34. Opressnig T, Thacker EL, Yu S, Fennaux M, Meng XJ, Halbur PG. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet Pathol 2004;41:624-640.
35. Dalsgaard K. Adjuvants. Vet Immunol Immunopathol 1987;17: 145-152.
36. Spickler AR, Roth J. Adjuvants in veterinary vaccines: Modes of action and adverse effects. J Vet Intern Med 2003;3:273-281.
37. Singh M, O'Hagan DT. Recent advances in veterinary vaccine adjuvants. Int J Parasitol 2003;33:469-478.
38. HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 2002;20 Suppl 3:34-39.
39. Messier S, Ross RF. Interactions of Mycoplasma hyopneumoniae membranes with porcine lymphocytes. Am J Vet Res 1991;52:1497-1502.
40. Romero-Rojas A, Reyes-Esparza J, Estrada-Parra S, Hadden JW. Immunomodulatory properties of Mycoplasma pulmonis. III. Lymphocyte stimulation and cytokine production by Mycoplasma pulmonis products. Int Immunopharmcol 2001;9-10:1699-1707.
41. Knudsen NS. PMWS update: Veterinary researchers continue to hunt for PMWS answers. Swine Pract 2005:4-7.
42. R (abstract). Proc 2nd Asian Pig Vet Soc Cong, 2005:226-227.
43. Alexopoulos C, Kritas SK, Papatsas I, Papatsiros VG, Tassis PD, Kyriakis SC. Efficacy of one and two shot vaccines for the control of enzootic pneumonia (EP) in a pig unit suffering from respiratory syndrome due to EP, PRRS and PMWS (Abstract) Proc 18th Vet Pig Soc, 2004:1:449.